Screening for Depression and Anxiety in Patients With Heart Disease

Depression Clinical Trial

Official title:

Screening for Depression and Anxiety in Patients With Heart Disease

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03203395
• Other study ID #: 2016/16558 (PVO)
• Secondary ID: 2016/16558
• Status: Completed
• Phase: N/A
• Start date: January 1, 2017
• Est. completion date: October 1, 2017

Study information

• Verified date: December 2019
• Source: Diakonhjemmet Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Depression is a risk factor for morbidity and mortality in patients with heart disease, and has a negative impact on quality of life, work capacity and treatment adherence. Screening for depression among heart patients are therefore recommended by the Norwegian Health Authorities. Also, symptoms of anxiety may negatively affect rehabilitation due to e.g. fear of physical activity and excessive worry. Patients currently receiving treatment for heart disease at Diakonhjemmet Hospital will be screened for symptoms of depression and anxiety. If such symptoms are detected, patients will be offered a counselling session with a clinical psychologist. Further, routines for collaborative communication between clinical psychologist, cardiologist and the patient's general physician will be emphasized.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 232
• Est. completion date: October 1, 2017
• Est. primary completion date: October 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Men and women over 18 years under treatment for myocardial infarction, heart failure, tachyarrhythmia and/or valvular heart disease at the Department of Internal Medicine, Diakonhjemmet Hospital.

Exclusion Criteria:

• Unable to provide informed consent.

• Unable to read and/or understand Norwegian.

• Unable to complete a survey.

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Collaboration
• Depression
• Depressive Disorder
• Depressive Symptoms
• Disease
• Heart Diseases
• Panic Attacks
• Panic Disorder

Intervention

Behavioral:
• Screening and counselling
Screening for symptoms of depression and anxiety in heart patients, giving advice for prevention and managing of such symptoms and stimulating collaborative care between the hospital and the general practitioner.

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
Diakonhjemmet Hospital	Extrastiftelsen, LHL – The Norwegian Heart and Lung Patient Organization

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Detection of symptoms of depression, anxiety and/or recent panic attack in heart patients.	All patients included in the study will be screened for symptoms of depression, anxiety and recent panic attack by filling out a survey consisting of questions from the Patient Health Questionnaire-2 (PHQ-2), the Generalized Anxiety Disorder Scale-2 (GAD-2) and a question about whether they experienced a panic attack in the last four weeks. Cut-off is set to a score of = 2 on PHQ-2 and/or GAD-2 and/or a positive answer on the question about panic attack.	15 minutes
Primary	Detection of patients with or at risk for depression and/or anxiety disorders.	Patients who screened positive for symptoms of depression, anxiety and/or panic attack will be asked to complete the Hospital Anxiety and Depression Scale (HADS). Patients with a HADS score of = 4 will be offered a counselling session with a clinical psychologist.	1 hour
Primary	Implementation of counselling for treatment and prevention of depression and anxiety disorders in heart patients.	Patients with a HADS score of = 4 will be offered a counselling session with a clinical psychologist aimed to treat and prevent depression and anxiety disorders in heart patients.	1-2 hours